0%
The vision of Deccan Hematolink 3.0 is to strengthen hematology education and encourage scientific collaboration among healthcare professionals while bringing global treatment advancements closer to clinical practice in India.
Deccan Hematolink 3.0 is a prestigious hematology and hemato-oncology conference that brings together some of the leading experts, clinicians, researchers, and healthcare professionals from across India and international institutions. The conference is designed to create a collaborative academic platform where modern developments, clinical advancements, and innovative treatment approaches in hematology are discussed in depth. The event focuses on improving awareness, diagnosis, treatment protocols, and patient outcomes in blood disorders and cancers. It also promotes interaction between experienced specialists and young medical professionals through scientific sessions, workshops, and research presentations. The conference emphasizes the integration of advanced technologies such as Artificial Intelligence, molecular diagnostics, precision medicine, and CAR-T therapy into modern hematology practice.
The primary aim of Deccan Hematolink 3.0 was to create a strong academic and scientific platform for healthcare professionals working in hematology, hemato-oncology, and bone marrow transplantation. The conference focused on sharing the latest advancements, treatment innovations, and research developments in blood disorders and cancers. It aimed to improve clinical knowledge, encourage multidisciplinary collaboration, and promote evidence-based patient care practices. Another important objective of the conference was to explore the growing role of Artificial Intelligence, molecular diagnostics, precision medicine, and modern therapies such as CAR-T cell therapy in transforming hematology and oncology care. The event also aimed to support young doctors, researchers, and postgraduate students by providing opportunities for learning, networking, and academic participation.
Deccan Hematolink 3.0 was conducted through a structured scientific program designed to provide both theoretical knowledge and practical clinical insights. The conference began with inaugural sessions and keynote addresses delivered by leading hematology experts. Multiple scientific sessions were organized throughout the event, covering topics such as leukemia, lymphoma, multiple myeloma, anemia, thrombosis, pediatric hematology, and bone marrow transplantation. The conference included panel discussions, expert lectures, case-based discussions, and interactive Q&A sessions where participants could engage directly with faculty members. Specialized masterclasses and workshops were conducted on molecular diagnostics, hematopathology, CAR-T therapy, and advanced transplant techniques. Young researchers and postgraduate students were encouraged to participate through abstract and research paper presentations, allowing them to present their clinical studies and innovations before expert panels. Sessions on Artificial Intelligence in hematology and oncology highlighted the future integration of technology into diagnosis, treatment planning, and patient management. The event also provided networking opportunities for doctors, researchers, healthcare organizations, and industry professionals to exchange knowledge, discuss collaborations, and strengthen academic relationships within the hematology community.
Deccan Hematolink 3.0 successfully established itself as a significant scientific gathering in the field of hematology and hemato-oncology. Through expert discussions, research presentations, and innovation-focused sessions, the conference contributed toward advancing hematology education, improving patient care, and strengthening the future of blood disorder and cancer treatment in India
Click the button below to browse the complete photo album and highlights from this event.
Open Photo Gallery